The price-to-earnings ratio for Progyny Inc (NASDAQ: PGNY) is above average at 52.14x. The 36-month beta value for PGNY is also noteworthy at 1.51. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for PGNY is 90.10M, and at present, short sellers hold a 7.33% of that float. The average trading volume of PGNY on May 09, 2024 was 878.64K shares.
PGNY) stock’s latest price update
Progyny Inc (NASDAQ: PGNY) has experienced a decline in its stock price by -2.72 compared to its previous closing price of 33.06. However, the company has seen a fall of -0.40% in its stock price over the last five trading days. CNBC Television reported 2024-04-05 that ‘Mad Money’ host Jim Cramer shares his small-cap healthcare stock picks.
PGNY’s Market Performance
Progyny Inc (PGNY) has experienced a -0.40% fall in stock performance for the past week, with a -10.54% drop in the past month, and a -19.18% drop in the past quarter. The volatility ratio for the week is 3.45%, and the volatility levels for the past 30 days are at 2.78% for PGNY. The simple moving average for the past 20 days is -2.14% for PGNY’s stock, with a -10.20% simple moving average for the past 200 days.
Analysts’ Opinion of PGNY
Many brokerage firms have already submitted their reports for PGNY stocks, with Leerink Partners repeating the rating for PGNY by listing it as a “Outperform.” The predicted price for PGNY in the upcoming period, according to Leerink Partners is $49 based on the research report published on February 26, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see PGNY reach a price target of $48. The rating they have provided for PGNY stocks is “Overweight” according to the report published on January 03rd, 2024.
Canaccord Genuity gave a rating of “Buy” to PGNY, setting the target price at $46 in the report published on September 27th of the previous year.
PGNY Trading at -7.71% from the 50-Day Moving Average
After a stumble in the market that brought PGNY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.45% of loss for the given period.
Volatility was left at 2.78%, however, over the last 30 days, the volatility rate increased by 3.45%, as shares sank -7.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.16% lower at present.
During the last 5 trading sessions, PGNY fell by -0.40%, which changed the moving average for the period of 200-days by -18.00% in comparison to the 20-day moving average, which settled at $32.73. In addition, Progyny Inc saw -13.50% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PGNY starting from Payson Norman, who sale 200 shares at the price of $56.29 back on Nov 23 ’24. After this action, Payson Norman now owns 580,656 shares of Progyny Inc, valued at $11,258 using the latest closing price.
Sturmer Michael E, the PRESIDENT of Progyny Inc, sale 4,515 shares at $31.95 during a trade that took place back on May 01 ’24, which means that Sturmer Michael E is holding 380,038 shares at $144,254 based on the most recent closing price.
Stock Fundamentals for PGNY
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.22 for the gross margin
The net margin for Progyny Inc stands at 0.06. The total capital return value is set at 0.11. Equity return is now at value 13.34, with 9.48 for asset returns.
Based on Progyny Inc (PGNY), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at 9.74. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is -47.11.
Currently, EBITDA for the company is 64.47 million with net debt to EBITDA at -1.22. When we switch over and look at the enterprise to sales, we see a ratio of 2.78. The receivables turnover for the company is 4.5for trailing twelve months and the total asset turnover is 1.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.44.
Conclusion
In summary, Progyny Inc (PGNY) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
